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Abstract 
Obesity is an important complex and chronic disease. Dietary 
arginine (2-amino 5-guanidinovaleric acid) supplementation represents a 
potentially novel and useful strategy for the management of obesity and 
diabetes. Oral supplementation with L-arginine reduced inflammation and 
oxidative stress associated with high carbohydrate, high fat feeding in rats. 
The main goal of the present study was to investigate beneficial effects of L-
arginine in the protection against intoxication on altered peroxisomal 
enzymes: D-amino acid oxidase (D-AAO) and catalase after high fat diet 
(H.F.D). 20 male Swiss albino rats (8 w old) were divided into two groups. 
Group 1: 5 rats (control), Group II a: 15 rats fed on H.F.D for 24 w. Group II 
b: 10 rats orally administered L-argenine in a dose of 622.14 mg/kg body 
weight /day for 12 weeks. 5 rats from each group were sacrificed and 
processed for ultrahistochemical studies of D-AAO and catalase enzymes. 
Our results revealed that in addition to lipid accumulation, the formation of 
myelin figures are related to impaired lipid degradation. After L-arginine 
supplementation, we observed that EM sections of liver have shown the 
formation of a peroxisomal reticulum at early times and the subsequent 
return of single peroxisome (PO). Also, we showed that following H.F.D, 
PO underwent significant changes in size, shape, and their contents of D-
AAO and catalase. After L-arginine treatment of animals receiving H.F.D, 
D-AAO and catalase activities returned to nearly control levels. This 
recovery could be attributed to capability of L-arginine to alter the 
antioxidant defense system induced by H.F.D. 
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Introduction 
Obesity is an important, complex and chronic disease. It is a severe 
metabolic disorder, characterized with increases in energy intake and a 
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decrease in energy output concerning body weight and glucose metabolism 
(Robert et al., 2006). 
Fatty diet is a significant factor causing obesity. It is known that 
obesity is associated with many chronic disorders such as a non-alcoholic 
fatty liver disease (NAFLD), and many important complications such as 
diabetes and coronary heart disease (Abu-Abid et al., 2002). It is also 
associated with insulin resistance and hyperlipidemia (Bailhache et al., 
2003). Liver steatosis is a well-known pathology in severely obese patients 
and is especially associated with visceral adiposity and diabetes (Adams et 
al., 2005). NAFLD is the most common liver disorder in the world, and in 
obesity, type 2 diabetes and related metabolic diseases, its incidence reaches 
70-90%. The disease is characterized by the accumulation of triacylglycerols 
inside liver cells, and the condition can progress into more serious liver 
disease, such as liver fibrosis, cirrhosis, and more rarely, liver carcinoma 
(Adams and Angulo, 2005).(5) Oxidative stress is now believed to be an 
important factor in the development of non alcoholic fatty liver disease 
(NAFLD) (Videla et al., 2006). 
Previous works have shown that feeding rats a high fat diet (57% of 
energy from fat) induces hepatic steatosis and liver damage, which are 
characteristic of NAFLD and thus provides a suitable model for the early 
stages of the disease (Safwat et al., 2009). In an electron microscopic 
examination; enlargement of microvilli, arising in number of lysosome, and 
cytoplasmic swelling were reported (Altunkaynak and Zbek, 2005). A liver 
damage was observed in rats fed with high-fat diet via increase of liver 
lipidperoxidation and decreased hepatic antioxidant enzyme activities 
(superoxide dismutase, catalase and glutathione peroxidase).  
Among type 2 diabetic patients, 50%-70% of individuals were 
diagnosed with NAFLD; in obese patients, that value increases to 
95% (Bloomgarden, 2005). Prolonged exposure to free fatty acids damages 
pancreatic β-cells and hepatocytes (Lupi et al., 2002). Furthermore, there 
was excessive fat accumulation in the liver damages mitochondria, which are 
the primary cellular sites for fatty acid utilization (Bak et al., 2011). 
Arginine (2-amino 5-guanidinovaleric acid) plays a role in the body 
as a free amino acid and as a component of most proteins, as well as the 
substrate for several non-proteins; nitrogen-containing compounds. As a free 
amino acid, arginine functions as an intermediate in the urea cycle. As one of 
the 20 common α-amino acids, arginine is an integral component of 
mammalian proteins. As a substrate for several non-proteins, nitrogen-
containing compounds, arginine indirectly participates in the rapid 
regeneration of adenosine triphosphate, cell proliferation, vasodilatation, 
neurotransmission, calcium release, and ultimately immunity (Nieves and 
Langkamp-Henken, 2002).  
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Dietary arginine supplementation represents a potentially novel and 
useful strategy for the management of obesity and diabetes (Miguez et al. 
2004). L-Arginine is an important dietary amino acid in both health and 
disease, especially of the cardiovascular system. However, supplementation 
may be needed in special conditions such as malnutrition, excessive 
ammonia production, burns, infections, peritoneal dialysis, rapid growth, 
urea synthesis disorders, and/or sepsis (Appleton, 2002).  Tousoulis et al, 
2007  suggested  that L-arginine supplementation may help treat individuals 
with atherosclerosis risk factors, such as hypercholesterolemia, hypertension, 
diabetes mellitus, kidney failure, hyperhomocysteinemia, smoking, and 
aging, all of which are conditions that are associated with reduced NO 
biosynthesis. It also has several metabolic functions as a substrate in the 
synthesis of creatine and NO (McConell and Kingwell, 2006). 
Peroxisomes (PO) are ubiquitous organelles contributing to various 
catabolic as well as anabolic pathways, for example, oxidation of long and 
very long-chain fatty acids, detoxification of reactive oxygen species, 
synthesis of plasmalogens (Schluter et al. 2007). Among the different tissues 
investigated so far, liver and kidney house the highest concentrations of these 
organelles (Islinger et al., 2007).  
D-Amino acid oxidase (D-AAO), a FAD-dependent peroxisomal 
flavoenzyme, catalyzes oxidation of D-amino acids to hydrogen peroxide 
and expressed in a wide range of species from yeasts to human (Pollegioni et 
al., 2007; Huang et al., 2012). There is no significant amino acid homology 
within the substrate binding region of D-AAO which may reflect the broad 
substrate specificity of this enzyme.   High levels of D-AAO expression and 
enzyme activity are found in the mammalian liver, kidney, and brain 
(Tishkov and Khoronenkova, 2005). Angermüller et al (2009) showed that 
D-AAO is significantly more active in preiportal than pericentral rat 
hepatocytes. Also, it concentrated in the central region of PO matrix 
compartment.      
Catalase is one of the most efficient enzymes known. CAT reacts 
with H2O2 to form water and molecular oxygen; and with H donors using 
peroxide in a kind of peroxidase activity. H2O2 is enzymically catabolized in 
aerobic organism by catalase and several peroxidases (SOD and GPx) 
(Pandya et al., 2010). 
The main goal of the present study is to investigate beneficial effects 
of L-arginine on two important enzymes D-AAO and Catalase after H.F.D 
and to show the role of L-argenine, a nitric oxide precursor, in inducing 
protection against toxicity of HFD. 
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Materials & Methods 
20 male Swiss albino rats (8 w old) were obtained from Medical 
Research Institute Animal house unit, Alexandria University. Rats were 
housed in a temperature and humidity controlled facility on a 12-h light: dark 
cycle. At 9 w of age rats were divided into two groups. 
Group 1: 5 rats considered as control 
Group IIa: 15 rats fed on High fat diet (H.F.D) in gradient g/100g 
diet :( Basic diet 82.8, Lard 10, Cholesterol 0.5, Bile acid 0.5, 
Propylthiouracil 0.2, AIN 76 Vitamin mix and AIN 76 mineral mix) for 24 w 
. 5 rats were sacrificed at the end of this period. 
Group IIb: 10 rats orally administered L-arg. In a dose of 622.14 
mg/kg b.w /day for 12 wk. 5 rats from control and experimental groups were 
sacrificed and processed for ultrahistochemical studies of two peroxisomal 
markers:  
1- D-amino acid oxidase enzyme (D-AAO) according to the method of 
Angermüller & Fahimi 1988. This method was summarized in brief: Liver 
was perfused with 0.9 ml NaCl saline via portal vein for 1 min, then slices 
from median lobe were fixed for 5 min. in 4F/G plus 2% sucrose were 
incubated for 60 min. at 37C0 in 3mM CeCl3 , 100mM Na azide and 
10mM D-proline in 0.1M Tris maleate buffer pH 7.8 . Sections were then 
post fixed in 2% OsO4 and processed for EM study. Control sections were 
incubated in the absence of D-proline. 
2- Catalase enzyme according to the method of Fahimi & Baumgart 1993. 
After perfusion and fixation for liver tissue slices were incubated in DAB 
solution (without H2O2) for 1 min., after washing the slices were 
incubated in DAB solution (With H2O2) for 15 min. Slices were washed 
and intensificated in 0.1M phosphate buffer, pH 7.2 for 5 min, sections 
were then fixed in 2% OsO4 and processed for EM study. 
 
Results 
Peroxisomes (PO) were numerous in the liver cells of control animals 
and usually appeared spherical and closely associated with smooth ER and 
mitochondria. They were filled with enzymes, especially catalase and D-
AAO. 
 
1. D-AAO 
Rat liver sections were stained for D-AAO using D-proline as a 
substrate. H2O2 released, oxidized Ce 3+ to cerium perhydroxide (an 
insoluble electron dense precipitate). Thus the staining intensity for cerium 
perhydroxide can be used as a marker to quantify the D-AAO activity in 
individual PO. PO with differential cerium staining appeared to be 
distributed throughout the whole cytoplasm. A direct association with other 
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organelles, such as SER or mitochondria was observed (Fig.1, 2). On 
prolonged administration of experimental diet, numerous lipid droplets 
appeared. In addition to lipid accumulation, rat liver after 24wk H.F.D. 
showing decreased activity of D-AAO (Fig.3). There are myelin figures that 
are related to impaired lipid degradation in the lysosomes in these conditions 
(Figs 3&4a). These figures originate from cisternal elements of the ER in the 
hepatocytes of intoxicated rats. After L-arginine supplementation (12wk) we 
observed that electron microscopic sections of regenerating rat liver showed 
the formation of peroxisomal reticulum at early times, the subsequent return 
of single PO and increased D-AAO activity around peroxisomal membranes 
(Fig.4b). 
  
2. Catalase  
In respect to catalase: The specificity of DAB staining of catalase 
was confirmed by the control reactions in which the specific substrate of the 
enzyme was omitted. The staining reaction of catalase was moderate in 
control liver cells, extensively localized in the matrix of PO and on their 
membranes (Fig 5). Following H.F.D. PO underwent significant changes in 
size, shape, and their contents of catalase. These alterations were mostly 
prominent after chronic dose of H.F.D. (24wk) and accompanied with strong 
catalase staining reaction in the matrix of PO and other organelles which 
were closely associated with them (SER and mitochondria).(Fig.6) We 
noticed that the ER and Golgi apparatus were well preserved (Fig.7). L-
arginine treatment of animals receiving H.F.D. returned catalase activity to 
control levels (Figs 8&9b). 
 
Discussion 
The peroxisomal B -oxidation system may play an important role in 
the control of lipid metabolism. It has been calculated that the relative contri-
bution of peroxisomal fatty acid oxidation is no more than 10% to overall 
hepatic oxidation of the physiologically important fatty acids palmitate and 
oleate, under normal conditions (Debeer and Mannaerts. 1983). The electron 
microscopic observations suggested that lipid metabolism may be an 
important factor in the control of peroxisome number and function in liver 
cells (Miyazawa et al., 1980). 
The changes in the peroxisomal enzyme activities are due to changes 
in the content in peroxisomal proteins. The 'normal' turnover rate of 
peroxisomal enzymes is rather low (Miyazawa et al., 1980). In this respect, it 
was enlightening to observe that antilipolytic agents induce the formation of 
autophagic vacuoles in liver cells, often containing peroxisomes. Also, 
Yamamoto & Fahimi (1987) showed that the peroxisomes in regenerating rat 
liver showed several distinctive features: a) marked variation in shape and 
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size, e.g., peroxisomes with tail-like extensions and tortuously elongated rod-
shaped ones, b) formation of peroxisomal clusters and, c) interconnections 
between adjacent peroxisomes suggesting cleavage or budding. 
Limiting the generation of reactive oxygen species, especially 
superoxide, hydrogen peroxide, lipid peroxides, hydroxyl radical, and lipid 
peroxyl radicals, caused limitation in the oxidative inactivation of NO to 
nitrite, nitrate, peroxynitrite, and lipid peroxynitrites (Gocke et al., 1999). 
The mechanisms responsible for the beneficial effects of L-arginine 
are likely complex, but ultimately involve altering the balance of energy 
intake and expenditure in favor of fat loss or reduced growth of white 
adipose tissue (Knight et al., 2010).  
Previous studies conducted in different animal models demonstrated 
that L-arginine reduced generation of superoxide anion (O2·−) and prevented 
the reduced expression of eNOS (Schneider et al., 2003). The balance 
between NO and O2·− plays an important role in the process of many 
cardiovascular and pulmonary diseases (Sud et al., 2007). Oral 
administration of L-arginine can also lower PH and prevent right ventricular 
hypertrophy (Sasaki et al., 2004). Hung et al (2008) have showed that 
supplementation with L-arginine significantly attenuated pulmonary and 
cardiac oxidative stress during exhaustive exercise in both young and aging 
rats.  
Other experiments show that L-arginine has direct antioxidant effects 
and that this is due to the alpha-amino group, a chemical moiety different 
from that necessary for NO biosynthesis (Lass et al., 2002; Alvares et al., 
2011). By simply acting as an antioxidant, L-arginine may scavenge 
superoxide or restore the crucial cofactor tetrahydrobiopterin (BH4) and 
thereby prevent eNOS-mediated superoxide production in an "uncoupled" 
status. In this area, L-arginine seems to be a good antioxidant couple that has 
been shown to inhibit the Fenton reaction and thus preventing the formation 
of hydroxyl radical (Rubbo et al., 2009). Lu et al (2010) showed that D-AAO 
inhibitors produce analgesia by blocking spinal H2O2 production rather than 
interacting with spinal D-serin. Tripath et al (2009) observed an increase in 
the activity of SOD and decreased the activity of XO in myocardial ischemic 
patients on oral administration of L-arginine 3g/day for 7 days 
Pharmacological treatment with L-arginine-induced protection 
against acute stress (Kurhalyuk, 2003), physical loading (Kurhalyuk and 
Tkachenko, 2006) and low resistance to hypoxia partially by reducing lipid 
hydroperoxides level (Tkachenko and Kurhalyuk, 2011). 
Paddon et al (2004) reported that enhancing arginine availability 
stimulated muscle protein synthesis without affecting muscle proteolysis in 
rabbits, thereby decreasing the availability of long-chain fatty acyl-CoA for 
triglyceride synthesis and of acetyl-CoA for fatty acid synthesis result in an 
European Scientific Journal   December 2013  edition vol.9, No.36  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
  
393 
 
overall increase in the oxidation of both glucose and fatty acids while 
possibly decreasing fat deposition.Several studies have also demonstrated 
that oral L-arginine has a protective function against attacks by reactive 
oxygen species (ROS), thereby attenuated or normalized obesity-related 
changes in heart, liver and pancrease (Lanteri et al., 2006; Alvares et al., 
2012). In addition, oral l-arginine administration reduced blood pressure in 
both normo- (Siani et al., 2000) and hyperglycaemic (Huynh & Tayek, 2002) 
conditions. Mendez & Balderas (2001) noted beneficial l-arginine effects on 
hyperglycaemia and dyslipidaemia in alloxan-induced diabetes mellitus. 
The lower lipolysis may have been due to greater NO production 
with L-arginine infusion since NO inhibits catecholamine-induced 
stimulation of lipolysis (Klatt et al., 2000). NO reduces glycerol release from 
isolated human adipocytes in vitro (Andersson et al., 1999), and also reduce 
fat mass in obese subjects with type-II diabetes mellitus (Fu et al., 2005).  21 
days of oral L-arginine treatment augmented the beneficial effects of a 
hypocaloric diet and exercise training program on glucose metabolism, 
insulin sensitivity and markers of oxidative stress in obese type 2 diabetics 
(Lucotti  et al., 2006). Arginine supplementation reduced the weight of 
abdominal (retroperitoneal) and epididymal adipose tissues (45 and 25%  
respectively) as well as serum concentrations of glucose (25%), triglycerides 
(23%), FFA (27%), homocysteine (26%,) dimethylarginines (18–21%), and 
leptin (32%).     
D-AAO is a peroxisomal flavoprotein that catalyses the oxidative 
deamination of D-amino acids to a-keto acids and the byproduct H2O2 
without producing ROS (Lu et al., 2012). Also the peroxisomal activity of D-
amino acid oxidase may be directly associated with specific metabolic 
functions of individual hepatocytes. Moreover, Po with significant 
differences in the D-amino acid oxidase activity can be also frequently 
observed within the same cell. D-amino acid oxidase shows a heterogeneous 
distribution in rat liver tissue (Islinger et al., 2010).  
Our present findings were in accordance with these previous studies 
where normal hepatocytes showed different D-AAO activity although there 
was heterogeneity in its distribution.   
Our present results revealed that in addition to lipid accumulation, the 
formation of myelin figures are related to impaired lipid degradation in the 
lysosomes in these conditions. These figures originate from cisternal 
elements of the ER in the hepatocytes of intoxicated rats. After L-arginine 
supplementation we observed that electron microscopic sections of 
regenerating rat liver have shown the formation of a peroxisomal reticulum 
at early times and the subsequent return of single PO. Moreover, the findings 
revealed that rat liver after 24wk H.F.D. showed a decreased activity of D-
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AAO while an increased D-AAO activity around peroxisomal membranes 
after L-arginine treatment was noted. 
Respecting catalase, these alterations were mostly prominent after 
chronic dose of H.F.D. (24wk) and accompanied with strong catalase 
staining reaction in the matrix of PO and other organellae which were closely 
associated with them (SER and mitochondria). Also our results showed that 
following H. F. D. PO underwent significant changes in size, shape, and their 
contents of catalase.  After L-arginine treatment of animals receiving H.F.D, 
catalase activity returned to control levels. This could reflect an altering in 
the antioxidant defense system induced by H.F.D.  In accordance with our 
findings, the activities of SOD and CAT in the liver were significantly (p < 
0.05) lowered in rats fed with high-fat diet than control group animals. Loss 
of CAT activity results in oxygen intolerance and triggers a number of 
deleterious reactions such as protein and DNA oxidation, and cell death 
(Nakbi et al., 2010). 
Also, DeGaener et al (1995) showed that in human fatty liver, PO 
were found to increase in both number and density, whereas their size and 
catalase activity were decreased.    
Conclusion, it is plausible to assume that L-arginine inhibit the lipid 
peroxidation process that is known to be triggered by ROS. In another word, 
L-arginine may have a beneficial prophylactic effect that altered lipid 
composition of membranes and may results in altered membrane integrity, 
permeability, and function. 
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Fig.1: Visualization of D-AAO in ultrathin section of rat liver using the cerium-technique. 
Note PO (arrows) with different D-AAO activities, those in the left show generally weaker 
activities, whereas those in the right exhibit a dark stain. Individual PO are marked by 
arrows bar = 3 m. 
 
 
Fig 2: Higher magnification showing intracellular heterogeneity of peroxisomal D-AAO 
activity (arrow heads) and in smooth endoplasmic reticulum (SER).  Note nascent PO 
budding from a proliferating peroxisomal reticulum (arrow head) bar = 1m. 
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Fig.3: Ultrathin sections of rat liver after 24wk H.F.D. showing decreased activity of D-
AAO.  Lipid fragments and crystal clefts (cc) were also observed. Bar = 1 m 
 
 
Fig.4a:  EM of rat liver 24wk H.F.D showing details of hepatocytes contains myelin figures 
(arrow heads). Their outer layers are continuous with the dilated ER. Bar = 1 m 
Fig.4b: After L-arg. treatment we observed that regenerating rat liver showing the formation 
of a peroxisomal reticulum and the subsequent return of single PO. Note traces of myelin 
figures (arrow head) and increased D-AAO activity around peroxisomal membranes. Bar = 1 
m. 
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Fig.5: EM of control rat liver showing normal small PO with moderate catalase activity in 
the matrixand on the membrane of PO. Note mitochondria (M) RER,SER and 
microtubules(MT) Bar = 2m. 
 
 
Fig.6: EM of rat liver 24wk H.F.D showing strong catalase activity especially in organelle 
closely associated with PO. Note also a few lipid droplets (L) in pericanalicular region. Bar 
= 10 nm. 
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Fig.7: EM of rat liver 24wk  H.F.D. Note  ER  well preserved and Golgi apparatus. Bar = 
10 nm. 
 
 
Fig.8: EM of rat liver after L-arg. treatment showing returned catalase activity to control 
levels. Bar = 10 nm. 
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Fig.9a: EM of rat liver (H.F.D.) showing the appearance of crystal clefts (CC) in the 
cytoplasm. Bar = 1 m. 
Fig.9b: EM of rat liver after L-argenine treatment showing that catalase enzyme returned 
more or less to control activity. Bar = 1 m. 
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